Andelyn Biosciences is a leading gene therapy CDMO and affiliate organization of Nationwide Children’s Hospital. We offer full spectrum rAAV, plasmid DNA and lentivirus cGMP development and manufacturing services. Our facility allows production of up to four different viral vector products simultaneously, supported through adherent and suspension platform technology. We provide manufacturability/feasibility assessments to de-risk your program and provide full regulatory and technical support. Our capacity to support phase 3 trials helps advance the field of gene therapy and supports the evolution of pivotal studies. Learn more at AndelynBio.com.